News and Announcements
Flamingo receives Award at MetLife Asia
- Published May 22, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Cre8tek Limited (ASX:CR8), owner of high-tech, Artificial Intelligence company and Cognitive Virtual Assistant platform provider, Flamingo Customer Experience Inc. (“Flamingo”), is pleased to announce that the company won a Judge Selection Award in MetLife Asia’s Start-up accelerator program.
KEY TAKEAWAYS:
- The award means Flamingo will work with Metlife Asia to deliver a trial of the Flamingo solution in one of Metlife’s Asian businesses. The value and terms of the contract are still to be determined.
- Flamingo was one of eight finalists in the program and one of only three prize winners following a demonstration event in Singapore on Friday 19 May 2017 where the competing businesses pitched their technology to nine senior MetLife executives.
Dr. Catriona Wallace, Cre8tek CEO and Flamingo founder, commented:
“We are delighted to win a Judge’s Selection Award and with it the opportunity to roll out a trial of our technology in Asia. The award is further validation of the Flamingo solution, and our participation in the collab program has given us valuable exposure in the Asian market and the opportunity to work with MetLifein the region.”
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
